WHO Model Prescribing Information: Drugs Used in Anaesthesia
(1989; 60 pages) [French] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoPremedication
Abrir esta carpeta y ver su contenidoGeneral anaesthetics and oxygen
Cerrar esta carpetaLocal anaesthetics
Ver el documentoBupivacaine
Ver el documentoLidocaine
Ver el documentoTetracaine
Ver el documentoEpinephrine (for use with local anaesthetics)
Abrir esta carpeta y ver su contenidoNon-opioid analgesics
Abrir esta carpeta y ver su contenidoOpioid analgesics and antagonists
Abrir esta carpeta y ver su contenidoMuscle relaxants and cholinesterase inhibitors
Abrir esta carpeta y ver su contenidoBlood substitutes
Abrir esta carpeta y ver su contenidoSolutions for correcting water and electrolyte imbalance
Abrir esta carpeta y ver su contenidoAntacid for use in obstetric practice
Ver el documentoAnaesthesia at the District Hospital
Ver el documentoSelected WHO publications of related interest
Ver el documentoBack cover
 

Tetracaine

Group: local anaesthetic agent
Solution (eye drops): 5 mg (hydrochloride)/ml (0.5%)

General information

Tetracaine is a local anaesthetic that penetrates the cornea and conjunctiva. It is effective after topical application to the eye within 30 seconds and anaesthesia persists for at least 15 minutes.

Clinical information

Uses

Short-lasting local anaesthesia of the cornea and conjunctiva.

Dosage and administration

One or 2 drops of 0.5% solution should be instilled into the conjunctival sac.

Contraindications

• Known hypersensitivity to tetracaine.
• Ocular inflammation or infection.

Precautions

The anaesthetized eye should be protected from dust and bacteriological contamination until sensation is fully restored.

Prolonged use has resulted in corneal opacities.

Adverse effects

A localized burning sensation may occur and, more rarely, lacrimation and photophobia.

Storage

Tetracaine eye drops should be kept in well-closed containers protected from light, and should not be allowed to freeze.

Ir a la sección anterior
Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 29 octubre 2018